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Genetic Susceptibil ity to Rhodococcus equi
C.M. McQueen, S.V. Dindot, M.J. Foster, and N.D. Cohen
Rhodococcus equi pneumonia is a major cause of morbidity and mortality in neonatal foals. Much effort has been made
to identify preventative measures and new treatments for R. equi with limited success. With a growing focus in the medical
community on understanding the genetic basis of disease susceptibility, investigators have begun to evaluate the interaction
of the genetics of the foal with R. equi. This review describes past efforts to understand the genetic basis underlying R. equi
susceptibility and tolerance. It also highlights the genetic technology available to study horses and describes the use of this
technology in investigating R. equi. This review provides readers with a foundational understanding of candidate gene
approaches, single nucleotide polymorphism-based, and copy number variant-based genome-wide association studies, and
next generation sequencing (both DNA and RNA).
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Rhodococcus equi pneumonia is an important dis-ease of foals most commonly characterized by
chronic progression associated with development of
large pulmonary abscesses.1 Treatment of R. equi
pneumonia is prolonged and expensive, and prevention
is limited because transfusion of hyperimmune plasma
is incompletely effective,2 chemoprophylaxis is inconsis-
tently effective3,4 and may promote antimicrobial resis-
tance,5 and no effective vaccine is currently available.6
Isolates of R. equi that are virulent in foals express the
virulence-associated protein A (VapA), which is
encoded by a gene, located within a pathogenicity
island, on an approximately 85- to 90-kilobase (kb)
plasmid. Expression of VapA alone, however, is not
sufficient to cause disease.7,8 Many different strains of
virulent (and avirulent) R. equi have been shown to be
present in a common environment (ie, the same farm),
and multiple genotypic virulent strains may exist even
in an individual foal with R. equi pneumonia.5,9–11
Although exposure to R. equi is widespread in farms
where foals are affected, only a variable proportion of
the foals will develop clinical disease at a given farm,
whereas other foals at the same location will not
develop disease.12,13 In addition, anecdotal reports by
veterinarians indicate that some mares recurrently have
affected foals, whereas other mares from the same envi-
ronment consistently have foals that do not develop
R. equi pneumonia. Taken together, these findings
support the possibility of an important role for a
genetic predisposition (ie, susceptibility, resistance, or
tolerance) to the development of R. equi pneumonia
and have prompted investigations of the genetic basis
for this disease. Pneumonia caused by R. equi is a com-
plex trait. Thus, it is unlikely that it will have a mono-
genic basis. Nevertheless, studying the genetic basis of
R. equi pneumonia is important because it could reveal
information about crucial biological processes and
pathways that influence the outcome of infection in
foals, and identifying these pathways and processes
might consequently lead to novel approaches for diag-
nostic testing, treatment, control, and prevention. The
purpose of this report is to review what is known
about the genetic predisposition to pneumonia caused
by R. equi in foals and to describe the genetic tech-
niques currently available to study the genetic determi-
nants for the development of R. equi pneumonia or
other diseases in horses. We begin by summarizing the
current literature regarding genetic associations with
R. equi pneumonia, and then discuss some more
advanced genetic tools available for future studies
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to further investigate the genetic basis of R. equi
pneumonia.
Literature Search
A literature search was conducted to identify English
language studies from any year that focused on foals,
R. equi, and genetics. Databases were searched in April
2014 through Ovid including CAB Abstracts, MED-
LINE, Embase, and BIOSIS. Search words included
(foals or equus or equine) and (r equi or Rhodococcus
equi*) and gene*, where the asterisk indicates trunca-
tion. Within each database, appropriate subject head-
ings or index terms also were added. A total of 744
articles were retrieved and deduplicated, with 5 articles
selected for inclusion. This search was updated in
September 2014.
Candidate Genes
We identified 5 studies that attempted to identify
genes associated with R. equi pneumonia. Four of these
5 studies have utilized a candidate gene approach
(Table 1). The candidate gene approach involves either
use of prior knowledge pertaining to known gene func-
tions that might predispose to the disease of interest
(eg, the interferon-gamma pathway and R. equi pneu-
monia)14,15 or use of genes implicated in other but simi-
lar diseases that could be potential candidates for
involvement(eg, genes important for Mycobacterium
tuberculosis which, like R. equi, is a gram-positive, fac-
ultative intracellular organism that replicates primarily
within macrophages and causes pneumonia and could
be potential candidates for R. equi pneumonia).16–18 To
the authors’ knowledge, the first candidate gene associa-
tion study of R. equi pneumonia compared the frequen-
cies of single nucleotide polymorphisms (SNPs) in the
transferrin gene (Tf) among Thoroughbred foals from
Kentucky that died of R. equi pneumonia with those of
control Thoroughbred mares.19 In one study, the Tf
gene was selected on the basis of its product’s ability to
bind iron because iron sequestration is a known host
defense mechanism against bacterial replication.20,21
The authors postulated that polymorphisms in the Tf
gene might result in enhanced (or decreased) iron bind-
ing, which then could confer a selective advantage (or
disadvantage) to survive infections with bacteria such as
R. equi.19 The authors used SNP frequencies to infer Tf
alleles present within the study population, and allele
frequencies were subsequently compared between the
case and control groups. The authors documented a sig-
nificant (P < 0.05) abundance of the Tf F allele and a
deficiency of the D1 allele among the cases (diseased
foals) when compared with controls. Limitations of this
study included the fact that the sample size was rela-
tively small, it was restricted to a single breed, a sepa-
rate population for validation was not included, and no
mechanistic studies (ie, documentation that the F allele
was associated with decreased iron-binding) were incor-
porated or cited. Nonetheless, a significant association
of SNPs in the Tf gene with R. equi pneumonia was
demonstrated, and this finding represented an important
advance in knowledge.
A later study seeking to identify a genetic predisposi-
tion to R. equi pneumonia utilized the candidate gene
approach by comparing frequencies of 22 genetic mark-
ers among 51 Thoroughbred foals from the Czech
Republic.22 These markers were either SNPs or poly-
morphic microsatellites in or near immune-related genes
that had been previously identified (except for 5 mark-
ers that were first identified in this study). No genetic
variants were significantly associated with R. equi pneu-
monia, but some genetic variants were significantly
associated with a higher burden of R. equi in tracheo-
bronchial aspirate (TBA) fluid from foals. Specifically,
loci on chromosome 10 and 15 were associated with
R. equi infection when comparing the subset of foals
with extreme phenotypes (ie, foals with the highest
numbers of R. equi in TBA fluid) to those with no
R. equi. The strongest association with TBA fluid phe-
notype was for the microsatellite HMS01 located on
chromosome 15 which encodes the genes for interleukin
(IL)-1b (IL1b) and the IL-1 receptor antagonist
(IL1RN). Although the associations were relatively
weak and the phenotype was for burden of R. equi in
TBA fluid (rather than for pneumonia caused by
Table 1. Genetic studies of Rhodococcus equi pneumonia in foals.
Author Study design Country Breed(s)
Number of
horses
Markers
investigated Observed outcome Findings
Mousel
et al.19
Candidate
gene
United
States
Thoroughbred N = 84 Tf SNPs Clinical pneumonia
or control
Allelic association of
Tf with disease
Horin
et al.22
Candidate
gene
Czech
Republic
Thoroughbred N = 51 SNPs,
Microsatellites
Burden of R. equi
in TBA fluid
Association of IL1RN
and IL1b with burden
of R. equi
Halbert
et al.29
Candidate
gene
United
States
Arabian and
Thoroughbred
N = 103 SLC11A1
SNPs
Clinical pneumonia
or control
Variation in SLC11A1
associated with disease
Horin
et al.30
Candidate
gene
Czech
Republic
Thoroughbred N = 51 SNPs Burden of R. equi
in TBA fluid
Association of IL7R
with burden of R. equi
McQueen
et al.52
GWAS United
States
Quarter Horse N = 72
N = 248
Genome-wide
SNPs
Clinical and
Subclinical
pneumonia,
or control
Associated SNP in
TRPM2 with disease
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R. equi), these results offer further evidence of a genetic
basis for host response to infection with R. equi.
A third study from our laboratory utilized previous
findings indicating association between the solute carrier
family 11 member 1 gene (SLC11A1) and susceptibility
to intracellular bacterial infections in other species of
animals.23–26 The SLC11A1 gene encodes a protein rele-
vant to innate immune responses to intracellular bacte-
ria.27,28 Direct sequencing of the beginning of the gene
transcript (ie, the 50 end of the gene) was used to iden-
tify SNPs that were compared between cases of R. equi
and unaffected foals (controls) among Arabian horses
at 2 farms (1 farm in Texas and 1 farm in Arizona). A
novel SNP, -57T, in the 50 untranslated region (UTR)
was significantly associated with R. equi pneumonia.29
The authors further screened for this polymorphism in
5 domestic horse breeds, donkeys, and zebras, and
found that it was represented in 4 of the 5 horse breeds.
The observation that this SNP was represented across
multiple breeds strengthened the study’s findings
because if a marker were present in only 1 breed, it
would be possible (if not probable) that the identified
marker was more likely associated with breed differ-
ences than disease. Limitations of this study included
the fact that association between the candidate gene
and disease was only assessed within a single breed at 2
farms, and no validation of the association in another
population was conducted. In addition, inconsistencies
in diagnostic practices for R. equi pneumonia among
farms in the study existed, which might have impacted
the results.29
A fourth candidate gene study investigated the fre-
quency of SNPs in selected immune response genes
from DNA samples collected from 31 Thoroughbred
foals from the Czech Republic30 that had been used in
a previous candidate gene study (described above).22
The candidate markers were used to asses allele fre-
quencies between the groups of foals classified on the
basis of a binary outcome using a cut-point of >5,000
colony forming units (CFU)/mL of vapA-positive
R. equi in TBA fluid. Twenty-five foals were categorized
as below the cut-point because they had no bacteria cul-
tured from them, and 6 were categorized as above the
cut-point.30 An association was identified between a
SNP in the IL-7 receptor (IL7R) gene and the presence
of >5,000 CFU of R. equi in TBA fluid. Limitations of
this study included lack of a validation population in
which the association could be replicated, and, similar
to the earlier study using these foals, the association
was not made between the marker and disease but
rather between the marker and the concentrations of
bacteria present in TBA fluid. Regardless of these limi-
tations, this study was scientifically important in that it
implicated the IL7R gene in particular, and innate
immunity in general, as having a role in host response
to infection with R. equi.
The candidate gene approach is a valid method for
genetic investigation and yielded positive associations in
the aforementioned studies, strengthening the plausibil-
ity of a genetic contribution to susceptibility or resis-
tance to R. equi pneumonia in foals. Moreover, the
commonality of identifying innate immune responses as
playing a role in host defense against infection with
R. equi in these various candidate gene association stud-
ies is important to our understanding of the pathogene-
sis of R. equi pneumonia.
Despite these positive results, the candidate gene
approach has important limitations for making genetic
associations. Bias is introduced into the study design by
selecting a small number of genes for evaluation, on the
basis of either function of the gene product(s) or prior
association of the gene with disease. This selection pro-
cess effectively eliminates the ability of the investigators
to examine both the enormous amount of genetic infor-
mation in the remainder of the genome or the relation-
ship and interaction of other genes with the genes of
interest.17 Other genetic elements present in the genome
(eg, sites critical to gene regulation) are missed by
restricting analysis to candidate genes, because in most
cases probes used to detect variation are not near each
other and offer no information about neighboring
genetic variation. Assessing variation across the genome
circumvents these limitations of the candidate gene
approach. Genome-wide studies in horses are now feasi-
ble because of recent technological developments.
Genome-Wide Association Studies
Genome-wide association studies (GWASs) rapidly
gained popularity after the sequencing of the genomes
of several animal species, including human beings.31–34
The completion of the sequencing and assembly of these
reference genomes (an assembly of the DNA sequence
and its chromosomal locations representing the genetic
baseline of a species) provided a tool that could be used
as a map indicating where elements of the genome
reside. Substantial efforts were then made to catalog the
locations of the genes and genetic variation identified
within these species.35,36 Single nucleotide polymor-
phisms proved useful for characterizing the genetic vari-
ation among individuals of a given species, and the
development of SNP array technology made it possible
to perform >1 million association tests simultaneously
of markers across the entire genome without the
expense or labor of genome sequencing.
Single nucleotide polymorphism arrays are glass
slides with genomic probes (sequences of DNA) that
capture SNPs present within a given species. Through a
hybridization process, the probes bind DNA of samples
to identify which polymorphisms are present in that
sample.37 These SNP arrays enabled clinical researchers
to compare clinically affected horses with unaffected
controls so as to examine the association of various
health disorders with markers on a genome-wide basis,
and the interplay among different genetic variants asso-
ciated with disease.38 Results from a GWAS are readily
identifiable because they typically are visualized by
plotting the negative logarithm of the P value for the
association of a given SNP with the outcome of interest
as the ordinate (vertical axis) and the chromosome
number as the abscissa (horizontal axis). The resultant
scatter plots are known as Manhattan plots because
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they resemble the skyline of a major city with some
points that tower over the majority of others. Determin-
ing the genome sequence of the domestic horse led to
the development of 2 equine SNP arrays that could be
used for GWAS by researchers.32,39
Currently, a single SNP array has been developed,
well characterized, made commercially available, and
utilized in numerous GWAS in horses. For example,
the EquineSNP70 BeadChip Arraya contains approxi-
mately 74,000 SNPs positioned across the equine gen-
ome that can be simultaneously tested to identify their
associations with a phenotype of interest.39,40 Recently,
a higher density SNP array with approximately 770,000
SNPs across the equine genome has been developed but
has not been characterized in peer-reviewed literature to
date. Several GWAS in horses using SNP arrays and
yielding positive associations have been reported.41–46
Genome-wide association studies rely on observing
different frequencies of alleles (identified by SNPs) that
segregate with a phenotype of interest. These associa-
tions have identified regions of interest (Fig 1A), which
are further investigated to understand what elements
(eg, genes, promoters, other variants),pathways or pro-
cesses are associated with the phenotype.
The reason marker associations require region inves-
tigation is because of linkage disequilibrium (LD),
which is defined as the nonrandom association of
genetic information.47 Linkage disequilibrium is a phe-
nomenon that allows for the prediction of the
nongenotyped genetic information around a genotyped
marker because of an assumption that the genetic
material around a marker differs, and thus can be
based on the allele represented by the marker (ie,
SNP). The use of LD to make disease associations
leverages inheritance patterns, selection, and evolution
and is a fundamental concept underlying GWAS. The
association of a marker, whether it is located in a gene
or in a noncoding region of the genome, should only
be treated as an indicator of the need to further inves-
tigate the area. An association of an SNP with disease
neither indicates that the SNP is causally associated
with the disease nor that the specific gene in which the
SNP lies is the gene of interest. An SNP only indicates
that there might be genetic variation in the area of the
genome where the SNP is located. The size of the area
of interest is largely described by the length of the LD
(ie, the number of bases for which another gene or
genetic element can be expected to be in LD with the
marker). Using LD to assist in making associations is
a powerful tool that is genome-wide and efficient
because not all markers across a genome must be
tested to find an associated region, should one exist.
The power of LD allows fewer markers to be present
on an array, and hence decreases the number of neces-
sary test corrections. Furthermore, the longer the LD
of the species the fewer SNPs are necessary to identify
significant associations. Estimates of LD for breeds of
horses are markedly longer than those for humans.48,49
Thus, one might expect to need fewer SNPs on an
equine array to have the same discriminatory power as
a human array or to have greater power in a GWAS
for horses than humans for an array of the same size
or density of SNPs.
Although SNP arrays are proving to be a powerful
tool for investigating the relationship of genetic and
phenotypic variation, challenges exist with validating
and reproducing results generated by SNP-based
GWAS. There are likely many contributing risk alleles
for all complex traits and complex diseases such that no
single allele can explain all of the phenotypic varia-
tion.50 This becomes problematic during replication
using different breeds and populations because the
markers identified might merely reflect breed differences,
or the markers might represent different alleles confer-
ring different levels of risk across breeds or populations.
The number of association studies in equine genetics
will only continue to increase and the equine research
community will continue to face these challenges.
Appropriate study designs, accurately defined and cate-
gorized phenotypes, and functional follow-up assays
will be essential to maximize the utility of GWAS
results in future studies.51
The first report of a GWAS with R. equi pneumonia
recently was published by our laboratory.52 The study53
population included 248 foals born in 2011 at a large
Quarter Horse breeding farm. For a separate study
characterizing the accuracy of screening tests for R. equi
pneumonia, foals at the farm were examined by tho-
racic ultrasonography every 2 weeks beginning at
3 weeks of age and continuing through 19 weeks of age
(or until weaned) to identify foals with areas of pul-
monary consolidation or abscess formation attributed
to R. equi infection. Farm personnel were blinded to
the ultrasonographic findings and a separate team of
individuals performed thoracic ultrasonography. Foals
at the farm were classified as having R. equi pneumonia
(N = 43; on the basis of clinical signs of pneumonia,
isolation of virulent R. equi from the TBA fluid, cyto-
logic evidence of sepsis in TBA fluid, and ultrasono-
graphic evidence of pulmonary consolidation or abscess
formation >1 cm in maximal diameter), no pneumonia
(N = 49; on the basis of the absence of clinical signs of
pneumonia and no ultrasonographic evidence of pul-
monary consolidation or abscess formation >1 cm
diameter), and subclinical pneumonia (N = 156; on the
basis of absence of clinical signs of pneumonia with
ultrasonographic evidence of pulmonary consolidation
or abscess formation >1 cm diameter). From each of
these 3 subpopulations of foals, a sample of 24 foals
was randomly selected for genotyping using the Equi-
neSNP70 BeadChip Array. Comparisons among the 3
groups identified a significant association of a region on
chromosome 26 that included the gene for the transient
receptor potential cation channel, subfamily M, member
2 (TRPM2).
These results are notable because the TRPM2 gene is
known to play a role in neutrophil function and recruit-
ment. In a study using TRPM2 knock-out mice and a
model of ulcerative colitis, TRPM2-deficient mice had
less tissue damage at sites of inflammation than did
wild-type mice.54 The association of the TRPM2 was
validated using polymerase chain reaction (PCR)-based
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genotyping of the locus in the remaining 176 study foals
that were not tested using the SNP array. The principal
limitations of this study were that only a single breed at
a single farm was studied, and that no association of
the genotype with function of the TRPM2 gene-product
or associated signaling pathways was identified.
Nonetheless, this study is interesting in that, consistent
with previous candidate gene studies, a gene related to
innate immunity was associated with R. equi pneumo-
nia, and the study provides further evidence of the
underlying genetic basis for R. equi pneumonia.
Copy Number Variants
Although the genetic determinants of phenotypic
variation are largely dependent on the gene or genes and
the manner in which they exert their effect (eg, altering
the biochemical properties of a protein, changing the
expression patterns or levels of messenger RNA), recent
studies have implicated copy number variants (CNVs) as
major determinants of phenotypic variation in humans
and animals.55–57 As the name implies, CNVs are char-
acterized by changes in the number of copies of DNA
between at least 2 individuals (Fig 1B).58 Their sizes can
range from hundreds to millions of base-pairs (bps).
Although they often are enriched in certain regions of
the genome that predispose to their formation, CNVs
have been detected throughout the genome, with many
CNVs involving multiple genes, individual genes, or
components of a single gene.
Several mechanisms have been shown to cause the for-
mation of CNVs. During meiosis in the germ cells,
homologous chromosomes align with each other to
exchange genetic information between the parental gen-
omes. This process, called homologous recombination
or crossing over, plays an instrumental role in expanding
Fig 1. Association studies, CNVs, and SNPs. (A) The colored blocks indicate different alleles or haplotypes present in the horse genome.
These have been identified by either a CNV or a SNP but any type of genetic variation can be used to identify alleles. The boxed regions
show a greater frequency of the orange allele in the cases compared to the controls. The increased frequency of this allele in the cases sug-
gests that it may harbor a variant(s) causing or contributing to the associated phenotype. (B) CNV – A represents a single copy of a gene;
CNV – B represents a duplication of the gene; and, CNV – C represents a deletion of the gene. These examples demonstrate how CNVs
can affect a single gene and can be used to identify different alleles in a population. SNPs, represented as red bases, offer the ability to
identify alleles because of their polymorphic nature. Either type of genetic variation can be used in a GWAS to identify disease-associated
alleles.
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the genetic diversity of a population. In rare instances,
however, the exchange of genetic material can occur
between 2 different sites (non-allelic homologous recom-
bination [NAHR]), resulting in an unequal exchange of
genetic material.59 Although NAHR often is the source
of many disease-causing CNVs, this process plays a key
role in the formation of gene families and the birth of
new genes. Naturallyoccurring DNA repair mechanisms
also can delete or duplicate DNA. For example, the
non-homologous end joining (NHEJ) and microhomol-
ogy-mediated end-joining (MMEJ) pathways are used to
repair double-stranded DNA breaks that occur in the
genome. During the repair of the breaks, the NHEJ and
MMEJ pathways either add or remove DNA to ligate
the broken strands back together.60–62 Fork stalling and
template switching (FoSTeS) is a mechanism used to cir-
cumvent a stalled replication complex during DNA syn-
thesis. When this happens, the FoSTeS machinery
identifies a similar sequence at a nearby replication site
to re-engage the stalled complex, leading either to a dele-
tion or duplication of the circumvented segment of
DNA.63 Microhomology-mediated break-induced repair
is another mechanism believed to give rise to CNVs
under stressed cellular conditions in which traditional
break-induced repair does not occur and therefore
homologous sequences are identified to continue replica-
tion.57,64 Overall, there are numerous pathways and
processes that can lead to the formation of a CNV.
Identification of CNVs across the genome has proven
to be challenging because of the dependency on probe
density to increase resolution and the physical limitation
of the number of probes that can be placed on a single
array. Array design technology continues to advance
and undoubtedly will increase our ability to identify
CNVs by enhancing genome resolution via probe den-
sity. Two studies in horses have used the EquineSNP70
BeadChip Array to search for the equine genome for
CNVs.65,66 The use of the equine SNP array to identify
CNVs highlights the usefulness of the SNP array, but,
there are limitations when SNP arrays are used solely
for identifying CNVs. The probes present on SNP
arrays are often evenly distributed across the genome,
thus spanning large distances and allowing only for the
identification of large CNVs. The SNP arrays also are
not well suited for identifying CNVs in structurally
complex regions (eg, gene families, segmentally dupli-
cated regions). Probe design often is difficult in these
regions, thus they are excluded from the array.67–69
Several studies have used technologies other than
SNP arrays to identify CNVs in horses, such as next
generation sequencing (NGS) and comparative genomic
hybridization arrays (aCGH).52,70–74 Arrays for CGH
are designed by tiling oligonucleotide probes across the
genome to which DNA of interest then can be hybri-
dized for the identification of CNVs (Fig 2). Use of
aCGH also has limitations for the identification of
CNVs, principally related to probe placement and den-
sity. The currently published equine arrays are a whole
genome tiling array (ie, probes tiled across the whole
genome) and an exon tiling array (ie, probes tiled across
noncoding and coding exons of genes).71,72 Thus, these
arrays only permit evaluation of CNVs within specific
regions of the genome. The results of studies identifying
CNVs by NGS are limited by variation in read-depth
(ie, the number of copies of sequences aligned to a
specific area) across the genome and the size of the
CNVs identified. Specifically, CNVs of lengths ranging
from 197 bp to 3.5 Mb have been identified and con-
firmed using a CGH array designed to identify CNVs in
genes of the equine genome.71 In a subsequent study
using NGS, CNVs ranging in length from 3.74 kb to
4.84 Mb were identified.70 There is, however, a trade-off
when using either approach. Targeted arrays can iden-
tify smaller CNVs, but they are only able to identify
CNVs within regions targeted on the array. Conversely,
NGS can be used to identify CNVs throughout the
entire genome, but NGS approaches to identifying
CNVs are limited because of their bias toward larger
CNV size. Although there are discrepancies among the
approaches used to identify CNVs, the studies to date
have identified CNVs in genes involved in similar path-
ways, such as sensory perception, signal transduction,
and immune-related pathways. Results from some CNV
studies of horses also have found concordant results
between aCGH and NGS whole genome sequencing in
which CNVs of horses have been shown to be enriched
in genes relating to sensory perception, signal transduc-
tion, and immune-related functions.71,72
Our laboratory conducted a CNV-based GWAS by
applying the aforementioned equine exon tilling array71
to the 72 foals studied in our SNP GWAS.48 Although
similar lengths and numbers of CNVs were observed
in these foals as in the previous report using this
array, no CNVs were significantly associated with
R. equi pneumonia in these foals. This finding does
not preclude the possibility that CNVs contribute to
susceptibility to R. equi pneumonia because only
CNVs within exons were considered. The CNVs
located within other elements such as promoters and
silencers that were not detected by the array might
influence the odds of foals developing R. equi pneumo-
nia. Moreover, sample size was small, which might
have limited our ability to detect anything less than
very strong associations. Future efforts should include
the design and implementation of adequately powered
studies using tiling arrays focused at gene promotors,
gene expression enhancers, and other regulatory ele-
ments that are both near and within genes. Much
remains to be investigated to characterize CNVs in
horses and to study the role of CNVs in susceptibility
to R. equi foal pneumonia and other diseases of
horses. Because CNVs represent a change in genetic
content (ie, deletions and duplications), they may have
the potential to greatly impact many phenotypes. A
4.6-kb duplication in an intron has been associated
with graying and melanomas in horses.75 A 16.1-kb
duplication has been shown to cause wrinkling of the
skin in Shar-Pei dogs.76 In humans, CNVs are believed
to play critical roles in neurodevelopmental disorders,
psychiatric disorders, and cancers.77,78 A number of
studies have described CNVs in cattle. Overall, the
CNVs identified to date are enriched in genes related
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to immune function and sensory perception, which
also has been observed in horses.79
Next Generation Sequencing Techniques
The invention of next generation sequencing (NGS)
technologies has opened a new world of opportunities
for understanding genetic variation and its role in dis-
ease pathogenesis. The NGS technology has enabled
rapid sequencing of the genomes of individuals at a low
cost and with maximum genome coverage.40 Before
NGS, the gold standard for sequencing technology was
automated Sanger sequencing.80 Sanger sequencing
technology was developed in the late 1970s and later
automated to increase throughput.81 Next generation
sequencing technologies differ among companies, but
they all share a principal advantage over Sanger
sequencing in that they are capable of sequencing multi-
ple DNA fragments (e, an entire genome) in a single
sequencing reaction (versus sequencing small fragments
piece-by-piece in multiple reactions).82 The opportuni-
ties provided by NGS technology are accompanied by
Fig 2. Comparative genomic hybridization method to identify CNVs in horses. (A) Genomic DNA is isolated from subject horses (cases
and controls) and a single reference horse. (B) Genomic DNA from the subject horses are independently labeled with a red dye and geno-
mic DNA from a single reference horse is labeled with a green dye. (C) Labeled DNA from a single subject horse and the reference horse
are mixed together at equal ratios and competitively hybridized onto a comparative genomic hybridization array. (D) Fluorescent image of
array after hybridization of subject and reference DNA. The spots on the array represent individual oligonucleotides. Yellow spots reflect
regions with equal DNA content, and red and green spots reflect unequal ratios of DNA between the subject and reference horse, respec-
tively. (E) Plot of normalized log2 ratios of oligonucleotides on the array. The Y-axis represents normalized log2 ratios of fluorescent sig-
nals for each spot on the array. The X-axis represents the relative genomic coordinates of each oligonucleotide. For example, a log 2 ratio
<1 and >-1 (black dots) indicates equal DNA content between the subject and reference horses. A log2 ratio >1 and <-1 indicates unequal
DNA content between the subject and reference horses.
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the challenge of managing and analyzing datasets of
enormous size. The ability of NGS to generate data has
out-paced the ability of the scientists to interpret it.
Developments in bioinformatic and biostatistical soft-
ware have facilitated our ability to visualize and make
inferences from large datasets.
Both DNA and RNA can be sequenced using NGS
methods. Sequencing the genome (DNA) and transcrip-
tome (RNA) offers 2 interrelated but distinct biological
approaches. Genome sequencing using NGS can char-
acterize all of the variants known to exist in gene
sequences, including single base changes (SNPs), inser-
tions and deletions, CNVs, and genetic variation in
nongenomic regions. The first application of NGS for
genome sequencing in horses yielded the genome
sequence of a Quarter Horse mare.70
Sequencing of the genome, however, does not reflect
which elements of the DNA are transcribed. Moreover,
transcription generally should be considered at the level
of a specific tissue or cell type because of intercellular
variation in gene expression. Although the DNA
sequence is common to all cells in an individual, the
genes expressed vary among cells or organs of the same
individual. Sequencing RNA yields a snapshot of the
expressed genes of the tissue or cell type that cannot be
identified by DNA sequencing. The process of sequenc-
ing RNA using NGS methods is termed RNA-Seq; it
may be applied either to total RNA (all forms of RNA)
or specific types of RNA. Most commonly, RNA-Seq is
applied to messenger RNA (mRNA) to reflect which
portions of the genome are being transcribed in the spec-
imen. Arriving at RNA-sequencing is a multistep pro-
cess which first requires deciding from which tissue or
body-fluid RNA should be extracted to best answer the
biological questions being asked. Briefly, isolated RNA
is converted to complementary DNA (cDNA) in order
to construct a library that represents all of the RNA iso-
lated and to be sequenced (Fig 3). The representative
libraries are then sequenced, generally in a paired-end
fashion. Paired-end sequencing reads are generated by
sequencing from both ends of a cDNA fragment (ie,
from the 50 end of both strands of the cDNA fragment).
Paired-end reads are extremely valuable because 2 com-
plementary pieces of information have been generated
about the same cDNA fragment, and this greatly
increases the accuracy of mapping these RNA sequences
back to their respective genes of the genome.
RNA-Sequencing is an invaluable tool for gaining
insight into biologically relevant questions such as dif-
ferences in gene expression by different alleles and gene
expression of a target specimen under different biologi-
cal or biochemical conditions. Several downstream
RNA-Seq processing and analysis programs can be used
to identify differentially expressed genes, novel tran-
scripts, and multiple isoforms of gene transcripts in
order to find answers to biological or clinical ques-
tions.83–85 The conclusions inferred from these analyses
can lead to identifying potential biological pathways
Fig 3. RNA-Seq flowchart. Isolated RNA is converted to cDNA, a stable molecule, which can then be amplified and sequenced. Sequenc-
ing reads are then aligned to the genome assembly (sequence only) to identify their locations based on nucleotide matches. Mapping the
reads to a gene annotation list will generate the number of sequencing reads that have aligned with a particular gene and are called counts.
These counts at any particular gene are representative of the amount of gene expression in the sample and can be compared across horses
to identify differentially expressed genes.
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and processes that can be targeted for the development
of novel interventions, including treatments and preven-
tative measures.
Several studies have reported the application of
RNA-Seq in horses in an attempt to identify differen-
tially expressed genes.86–95 To the authors’ knowledge,
the first report of RNA-Seq in horses was an effort to
characterize the transcriptome and tissue-specific expres-
sion profiles from 8 equine tissues.94 A subsequent
study focused on characterizing gene expression by
RNA-Seq in immunologically active tissues.95 Investiga-
tors have used RNA-Seq to characterize the expression
profile of genes critical to the differentiation and regula-
tion of cells during embryogenesis,90 and to characterize
the expression and inferred function of RNAs in the
equine sperm transcriptome.89 Several studies also have
used RNA-Seq in horses to identify differentially
expressed genes when comparing blood, muscle (ob-
tained by biopsy), or both before and after exercise or
racing.86,87,92 These studies have successfully identified
pathways involved in stress during and while recovering
from exercise. Other’s studies have sought to answer a
more specific question such as identifying expression
differences in the cartilage of the metacarpophalangeal
joints of young and old horses in an attempt to shed
light on genes involved in the development and aging of
cartilage.93 Use of RNA-Seq of hoof lamellar basal
epithelial cells has been performed to identify cell-sig-
naling pathways indicative of the early stages of lamini-
tis.91 Using RNA-Seq, an association has been
demonstrated of a long terminal repeat (a genetic ele-
ment inserted in the past by conversion of viral RNA
to cDNA and subsequently incorporated in the genome
of the host) with congenital stationary night blindness
and leopard spotting in horses.88
Our laboratory currently is analyzing RNA-Seq data
to identify differentially expressed genes of foals repre-
senting the 3 genotypes of the TRPM2 SNP identified
in our SNP-based GWAS to better understand the role
of this (and possibly other) gene in susceptibility to
R. equi pneumonia. We are also currently applying
RNA-Seq to leukocytes collected from healthy and
R. equi-affected foals to gain insights about gene expres-
sion of these immune-related cells. These studies will
further our understanding of R. equi pathogenesis and
hopefully identify critical biological pathways and pro-
cesses involved in disease development.
The genetic basis of a common and complex disease
such as R. equi pneumonia is likely polygenic. Gene
expression profiling by RNA-Seq, thus, will be an essen-
tial step in understanding the relationships and interac-
tions of multiple genes with this disease. The
identification of genes that are up- or down-regulated
after pathogen exposure can reveal host responses criti-
cal for defense against infection. When evidence of
differential gene expression is identified by RNA-Seq
(or other methods), it then becomes necessary to under-
stand the mechanistic cause driving the change in
expression(ie, variation within regulatory elements,
changes in epigenetic modifications, structural variation,
post-transcriptional and post-translational modifica-
tions).
Conclusions
Research findings regarding genetic relationships with
disease continue to substantiate that most common and
complex diseases are not monogenic. This likely is true
for R. equi pneumonia. The evidence to date, as sum-
marized in this review, indicates that susceptibility to
R. equi pneumonia is not controlled by a single gene. It
is increasingly clear that both innate and adaptive
immune responses as well as their interactions are criti-
cal for protecting foals against R. equi infection.
Genetic association studies have specifically implicated
innate immune responses, but innate immune responses
are critical for orchestrating adaptive immune responses
and it may be an oversimplification to dichotomize
these responses. It is likely that there also are epigenetic
factors involved in regulating the gene transcription of
critical immune-related genes, which adds further com-
plexity to the pathogenesis of R. equi pneumonia in
foals. Future proteomic studies also will be required to
follow-up on promising genetic findings as protein con-
centrations, structures, and interactions are critical to
disease development.96 Proteomic studies may be able
to answer critical questions such as protein concentra-
tions in diseased and nondiseased foals and variable
consequences related to protein concentrations and their
interactions, which cannot be answered with molecular
genetic techniques and sequencing. With more geno-
typic–phenotypic associations being identified in horses,
it will be challenging to investigate the causal implica-
tions of genetic variants with functional assays. Mecha-
nistic studies (eg, knock-out or knock-in genes) can be
become very expensive and would not be feasible in
horses. Developing rodent models of important equine
diseases and use of mechanistic studies in cell culture
assay will be required to understand the functional con-
sequences of identified associations with genetic mark-
ers. Moreover, it will be important to remain mindful
of the agent-related and environmental factors that con-
tribute to disease development. No single genetic tool
or technique will identify the factors that render some
foals susceptible to R. equi, whereas others in the same
environment remain clinically unaffected. The future
will require a multifaceted approach to integration and
analysis of data from multiple sources to successfully
identify the critical pathways and processes. We believe
that molecular genetic and epigenetic methods will play
an important role in solving the complex riddle of sus-
ceptibility to R. equi pneumonia in foals.
Footnote
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